These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 28283201)

  • 1. Reversing the Paradigm: Protein Kinase C as a Tumor Suppressor.
    Newton AC; Brognard J
    Trends Pharmacol Sci; 2017 May; 38(5):438-447. PubMed ID: 28283201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase C as a tumor suppressor.
    Newton AC
    Semin Cancer Biol; 2018 Feb; 48():18-26. PubMed ID: 28476658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase C: perfectly balanced.
    Newton AC
    Crit Rev Biochem Mol Biol; 2018 Apr; 53(2):208-230. PubMed ID: 29513138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-associated protein kinase C mutations reveal kinase's role as tumor suppressor.
    Antal CE; Hudson AM; Kang E; Zanca C; Wirth C; Stephenson NL; Trotter EW; Gallegos LL; Miller CJ; Furnari FB; Hunter T; Brognard J; Newton AC
    Cell; 2015 Jan; 160(3):489-502. PubMed ID: 25619690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PHLPPing the balance: restoration of protein kinase C in cancer.
    Tovell H; Newton AC
    Biochem J; 2021 Jan; 478(2):341-355. PubMed ID: 33502516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression.
    Isakov N
    Semin Cancer Biol; 2018 Feb; 48():36-52. PubMed ID: 28571764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-associated mutations in protein kinase C theta are loss-of-function.
    Hodapp SJ; Gravel N; Kannan N; Newton AC
    Biochem J; 2024 Jun; 481(12):759-775. PubMed ID: 38752473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase C in cancer: The top five unanswered questions.
    Cooke M; Magimaidas A; Casado-Medrano V; Kazanietz MG
    Mol Carcinog; 2017 Jun; 56(6):1531-1542. PubMed ID: 28112438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and phorbol ester-induced down-regulation of protein kinase C isozymes in osteoblasts.
    Sanders JL; Stern PH
    J Bone Miner Res; 1996 Dec; 11(12):1862-72. PubMed ID: 8970887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploitation of protein kinase C: a useful target for cancer therapy.
    Ali AS; Ali S; El-Rayes BF; Philip PA; Sarkar FH
    Cancer Treat Rev; 2009 Feb; 35(1):1-8. PubMed ID: 18778896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase C isozyme-mediated cell cycle arrest involves induction of p21(waf1/cip1) and p27(kip1) and hypophosphorylation of the retinoblastoma protein in intestinal epithelial cells.
    Frey MR; Saxon ML; Zhao X; Rollins A; Evans SS; Black JD
    J Biol Chem; 1997 Apr; 272(14):9424-35. PubMed ID: 9083081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations of mouse models during tumorigenesis revealed essential but distinct in vivo functions among the PKC family.
    Leitges M
    Adv Biol Regul; 2020 Dec; 78():100756. PubMed ID: 32992232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Regulation of Gene Expression in Lung Cancer Cells by Diacyglycerol-Lactones and a Phorbol Ester Via Selective Activation of Protein Kinase C Isozymes.
    Cooke M; Casado-Medrano V; Ann J; Lee J; Blumberg PM; Abba MC; Kazanietz MG
    Sci Rep; 2019 Apr; 9(1):6041. PubMed ID: 30988374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pros and cons of targeting protein kinase C (PKC) in the management of cancer patients.
    Leskow FC; Krasnapolski MA; Urtreger AJ
    Curr Pharm Biotechnol; 2011 Nov; 12(11):1961-73. PubMed ID: 21470133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isozyme-specific abnormalities of PKC in thyroid cancer: evidence for post-transcriptional changes in PKC epsilon.
    Knauf JA; Ward LS; Nikiforov YE; Nikiforova M; Puxeddu E; Medvedovic M; Liron T; Mochly-Rosen D; Fagin JA
    J Clin Endocrinol Metab; 2002 May; 87(5):2150-9. PubMed ID: 11994357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-specific regulation of CA(V)2.2 channels by protein kinase C isozymes betaII and epsilon.
    Rajagopal S; Fang H; Oronce CI; Jhaveri S; Taneja S; Dehlin EM; Snyder SL; Sando JJ; Kamatchi GL
    Neuroscience; 2009 Mar; 159(2):618-28. PubMed ID: 19167461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indolactam and benzolactam compounds as new medicinal leads with binding selectivity for C1 domains of protein kinase C isozymes.
    Irie K; Nakagawa Y; Ohigashi H
    Curr Pharm Des; 2004; 10(12):1371-85. PubMed ID: 15134488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C and cancer: what we know and what we do not.
    Garg R; Benedetti LG; Abera MB; Wang H; Abba M; Kazanietz MG
    Oncogene; 2014 Nov; 33(45):5225-37. PubMed ID: 24336328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer drug-mediated induction of multidrug resistance-associated genes and protein kinase C isozymes in the T-lymphoblastoid cell line CCRF-CEM and in blasts from patients with acute lymphoblastic leukemias.
    Beck JF; Brügger D; Brischwein K; Liu C; Bader P; Niethammer D; Gekeler V
    Jpn J Cancer Res; 2001 Aug; 92(8):896-903. PubMed ID: 11509123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Move over protein kinase C, you've got company: alternative cellular effectors of diacylglycerol and phorbol esters.
    Brose N; Rosenmund C
    J Cell Sci; 2002 Dec; 115(Pt 23):4399-411. PubMed ID: 12414987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.